Leonidas C Platanias

Medicine & Life Sciences

1. Interferons 100%
2. Phosphotransferases 46%
3. Interferon Type I 44%
4. Phosphorylation 41%
5. p38 Mitogen-Activated Protein Kinases 34%
6. TOR Serine-Threonine Kinases 34%
7. Acute Myeloid Leukemia 32%
8. Arsenic Trioxide 27%
9. Interferon alpha-beta Receptor 26%
10. Protein Biosynthesis 25%
11. Tyrosine 23%
12. Genes 23%
13. Growth 22%
14. Leukemia 19%
15. Neoplasms 18%
16. Proteins 17%
17. Phosphatidylinositol 3-Kinase 17%
18. Apoptosis 16%
19. Hematopoiesis 15%
20. Tretinoin 15%
21. Leukemia, Myelogenous, Chronic, BCR-ABL Positive 15%
22. Interferon Receptors 15%
23. Cell Line 15%
24. Phosphatidylinositol 3-Kinases 14%
25. Mechanistic Target of Rapamycin Complex 1 14%
26. Mechanistic Target of Rapamycin Complex 2 14%
27. Antiviral Agents 14%
28. 70-kDa Ribosomal Protein S6 Kinases 14%
29. Cytokines 14%
30. Cohort Effect 13%
31. Acute Promyelocytic Leukemia 13%
32. Oncogene Proteins 13%
33. Circulating Tumor DNA 13%
34. Myeloid Cells 13%
35. Protein Kinase C 13%
36. Therapeutics 12%
37. Antineoplastic Agents 12%
38. Eukaryotic Initiation Factor-4E 11%
39. Primary Effusion Lymphoma 11%
40. Bone Marrow 11%
41. Transforming Growth Factors 11%
42. Glioblastoma 10%
43. Autophagy 10%
44. Protein-Tyrosine Kinases 10%
45. Hydroxymethylglutaryl-CoA Reductase Inhibitors 9%
46. interferon regulatory factor-8 8%
47. src Homology Domains 8%
48. Transcriptional Activation 8%
49. Myelodysplastic Syndromes 8%
50. Pharmacology 8%